A deep dive into immune responses to cancer vaccines plus immunotherapy – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn:  .

“David Reardon, MD, is doing a deep dive into the immune responses of patients who are receiving cancer vaccines plus immunotherapy.

For patients with glioblastoma, timing is everything. The average time to recurrence after surgery is six or seven months. It takes several months to create a personalized vaccine. Once the vaccine is given to the patient, it takes at least one to two months for the immune system to begin mounting an immune response.

‘We’re literally in a race against the tumor’, says Reardon.

Learn about how Reardon and other Dana-Farber researchers are working to advance personal cancer vaccines.”

Further infromation.
Source: Dana-Farber Cancer Institute/LinkedIn